OSAM
KYNB

O'Shaughnessy Asset Management’s Kyntra Bio KYNB Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-162
Closed -$41K – 1652
2021
Q3 		$41K Sell
162
-13
-7% -$4.61K ﹤0.01% 1724
2021
Q2 		$117K Buy
175
+70
+67% +$40.3K ﹤0.01% 1244
2021
Q1 		$91K Hold
105
– – ﹤0.01% 1231
2020
Q4 		$97K Buy
+105
New +$110K ﹤0.01% 1076

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

O'Shaughnessy Asset Management's KYNB Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 162 shares — an estimated $41K sold.

O'Shaughnessy Asset Management first reported a position in KYNB in Q4 2020 and held it in 4 quarters. The position peaked at $117K in Q2 2021. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 162 Kyntra Bio shares in Q4 2021, an estimated $41K.
  • O'Shaughnessy Asset Management first reported a position in Kyntra Bio in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's Kyntra Bio position peaked at $117K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.